12.00
1.55 (14.83%)
1.55 (14.83%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 1,167,278 |
|
|||||
| News | - | ||||||
| Day High | 12.20 | Low High |
|||||
| Day Low | 10.79 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Cabaletta Bio Inc | CABA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 1.55 | 14.83% | 12.00 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 11.32 | 10.79 | 12.20 | 11.86 | 10.45 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,537 | 1,167,278 | $ 11.38 | $ 13,278,950 | - | 0.59 - 12.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:27 | 64 | $ 12.00 | USD |
Period:
Draw Mode:
Cabaletta Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 349.69M | 29.14M | 27.68M | $ - | $ - | -1.80 | -6.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 366.00k | 4.10% |
Cabaletta Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CABA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 10.90 | 12.20 | 9.50 | 11.01 | 772,847 | 1.10 | 10.09% |
| 1 Month | 9.09 | 12.20 | 8.26 | 10.30 | 767,104 | 2.91 | 32.01% |
| 3 Months | 2.40 | 12.20 | 1.90 | 6.71 | 893,982 | 9.60 | 400.0% |
| 6 Months | 1.36 | 12.20 | 0.59 | 2.93 | 1,442,719 | 10.64 | 782.35% |
| 1 Year | 2.89 | 12.20 | 0.59 | 2.81 | 811,451 | 9.11 | 315.22% |
| 3 Years | 17.47 | 19.63 | 0.59 | 4.53 | 386,027 | -5.47 | -31.31% |
| 5 Years | 9.45 | 19.63 | 0.59 | 4.73 | 365,576 | 2.55 | 26.98% |
Cabaletta Bio Description
| Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAAR, T cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CAAR T cell product candidate was designed based on the clinically validated and commercially approved Chimeric Antigen Receptor, or CAR, T cell technology that is marketed for the treatment of B cell cancers. |